SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML

被引：75
|
作者：
Laborde, R. R. [1 ]
Patnaik, M. M. [1 ]
Lasho, T. L. [1 ]
Finke, C. M. [1 ]
Hanson, C. A. [2 ]
Knudson, R. A. [3 ]
Ketterling, R. P. [3 ]
Pardanani, A. [1 ]
Tefferi, A. [1 ]
机构：
[1] Mayo Clin, Dept Med, Div Hematol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Lab Med, Div Hematopathol, Rochester, MN USA
[3] Mayo Clin, Dept Lab Med, Cytogenet Div, Rochester, MN USA
来源：
LEUKEMIA | 2013年 / 27卷 / 10期
关键词：
SCHINZEL-GIEDION SYNDROME; ACUTE MYELOID-LEUKEMIA; MODEL;
D O I：
10.1038/leu.2013.97
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2100 / 2102
页数：4
相关论文
共 50 条
  • [41] Detection of subclonal SETBP1 and JAK3 mutations in juvenile myelomonocytic leukemia using droplet digital PCR
    Manabu Wakamatsu
    Yusuke Okuno
    Norihiro Murakami
    Shunsuke Miwata
    Hironobu Kitazawa
    Kotaro Narita
    Shinsuke Kataoka
    Daisuke Ichikawa
    Motoharu Hamada
    Rieko Taniguchi
    Kyogo Suzuki
    Nozomu Kawashima
    Eri Nishikawa
    Atsushi Narita
    Nobuhiro Nishio
    Seiji Kojima
    Hideki Muramatsu
    Yoshiyuki Takahashi
    Leukemia, 2021, 35 : 259 - 263
  • [42] Clinical Significance of CSF3R, SRSF2 and SETBP1 mutation in Chronic Neutrophilic Leukemia and Chronic Myelomonocytic Leukemia
    Qiao, Chun
    Ouyang, Yuan
    Zhang, Sujiang
    BLOOD, 2015, 126 (23)
  • [43] A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1
    Burgstaller, Sonja
    Stauder, Reinhard
    Kuehr, Thomas
    Lang, Alois
    Machherndl-Spandl, Sigrid
    Mayrbaeurl, Beate
    Noesslinger, Thomas
    Petzer, Andreas
    Valent, Peter
    Greil, Richard
    Thaler, Josef
    LEUKEMIA & LYMPHOMA, 2018, 59 (05) : 1121 - 1126
  • [44] Treatment Outcomes and Prognostic Factors in 66 Patients with Chronic Myelomonocytic Leukemia (CMML) in a Single Center
    Wang, Chao
    Wang, Zhiqiong
    Meng, Fankai
    Luo, Li
    Liu, Xian
    Shi, Jiayu
    Huang, Lifang
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 7843 - 7854
  • [45] RAS mutations are associated with monocytic differentiation in myeloid leukemias and are an adverse prognostic factor in chronic myelomonocytic leukemia (CMML)
    Valbuena, JR
    Rassidakis, G
    Estey, E
    Luthra, R
    Yin, C
    Medeiros, LJ
    Jones, D
    LABORATORY INVESTIGATION, 2005, 85 : 255A - 255A
  • [46] PROGNOSTIC VALUE OF MUTATIONS IN ASXL1 IN CHRONIC MYELOMONOCYTIC LEUKEMIA
    Almorox Rebeca, Bailen
    Gonzalez Julia, Suarez
    Carolina, Martinez-Laperche
    Noemi, Fernandez-Escalada
    Maria, Chicano-Lavilla
    Diego, Carbonell
    Patricia, Font
    Santiago, Osorio
    Jose Lui, Diez-Martin
    Ismael, Buno
    HAEMATOLOGICA, 2016, 101 : 153 - 154
  • [47] Secondary Mutations of JAK3 and SETBP1 in Juvenile Myelomonocytic Leukemia and Their Propagating Capacity; A Report from the AIEOP Study Group
    Bresolin, Silvia
    De Filippi, Paola
    Vendemini, Francesca
    Masetti, Riccardo
    Locatelli, Franco
    te Kronnie, Geertruy
    BLOOD, 2014, 124 (21)
  • [48] Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia
    Kim, Hyun-Young
    Lee, Ki-O
    Park, Silvia
    Jang, Jun Ho
    Jung, Chul Won
    Kim, Sun-Hee
    Kim, Hee-Jin
    ANNALS OF LABORATORY MEDICINE, 2018, 38 (06) : 495 - +
  • [49] Differential Prognostic Impact of IDH1 and IDH2 Mutations in Chronic Myelomonocytic Leukemia
    Walsh, Connor M.
    Hunter, Anthony
    Lasho, Terra
    Finke, Christy
    Komrokji, Rami S.
    Shah, Mithun V.
    Tefferi, Ayalew
    Mangaonkar, Abhishek A.
    Howard, Matthew T.
    Gangat, Naseema
    Al-Kali, Aref
    Al Ali, Najla
    Padron, Eric
    Patnaik, Mrinal M.
    BLOOD, 2021, 138 : 3684 - +
  • [50] Differential prognostic impact of IDH1 and IDH2 mutations in chronic myelomonocytic leukemia
    Connor Walsh
    Anthony Hunter
    Terra Lasho
    Christy Finke
    Rhett Ketterling
    Rami Komrokji
    Ayalew Tefferi
    Abhishek Mangaonkar
    Matthew Howard
    Naseema Gangat
    Aref Al-Kali
    Najla Al Ali
    Eric Padron
    Mrinal M. Patnaik
    Leukemia, 2022, 36 : 1693 - 1696
12345